Healthcare provider profile · identity verified

Shuja Hassan

Internal Medicine · PITTSBURGH, PA · NPI 1225002835

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	483	98
Amlodipine Besylate	Amlodipine Besylate	325	64
Eliquis	Apixaban	279	35
Levothyroxine Sodium	Levothyroxine Sodium	278	44
Gabapentin	Gabapentin	220	39
Sertraline Hcl	Sertraline Hcl	208	33
Pantoprazole Sodium	Pantoprazole Sodium	195	46
Furosemide	Furosemide	184	44
Potassium Chloride	Potassium Chloride	183	36
Metoprolol Tartrate	Metoprolol Tartrate	165	25
Losartan Potassium	Losartan Potassium	151	42
Tamsulosin Hcl	Tamsulosin Hcl	142	29
Donepezil Hcl	Donepezil Hcl	137	22
Carvedilol	Carvedilol	136	20
Omeprazole	Omeprazole	135	28
Escitalopram Oxalate	Escitalopram Oxalate	131	33
Famotidine	Famotidine	129	29
Mirtazapine	Mirtazapine	127	25
Buspirone Hcl	Buspirone Hcl	108	20
Duloxetine Hcl	Duloxetine Hcl	103	19
Metoprolol Succinate	Metoprolol Succinate	97	22
Montelukast Sodium	Montelukast Sodium	92	12
Xarelto	Rivaroxaban	92	12
Lisinopril	Lisinopril	91	25
Metformin Hcl	Metformin Hcl	91	24
Trazodone Hcl	Trazodone Hcl	89	27
Allopurinol	Allopurinol	86	14
Spironolactone	Spironolactone	84	15
Prednisone	Prednisone	81	16
Tramadol Hcl	Tramadol Hcl	80	25
Lorazepam	Lorazepam	73	15
Quetiapine Fumarate	Quetiapine Fumarate	70	18
Pravastatin Sodium	Pravastatin Sodium	67	13
Tradjenta	Linagliptin	63	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	61	13
Olanzapine	Olanzapine	61	13
Bumetanide	Bumetanide	60	suppressed
Risperidone	Risperidone	58	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	56	14
Finasteride	Finasteride	54	suppressed
Simvastatin	Simvastatin	54	15
Clopidogrel	Clopidogrel Bisulfate	52	15
Rosuvastatin Calcium	Rosuvastatin Calcium	51	11
Jardiance	Empagliflozin	49	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	46	suppressed
Myrbetriq	Mirabegron	46	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	42	suppressed
Fluticasone Propionate	Fluticasone Propionate	42	20
Albuterol Sulfate Hfa	Albuterol Sulfate	40	18
Bupropion Xl	Bupropion Hcl	40	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	40	suppressed
Memantine Hcl	Memantine Hcl	40	suppressed
Latanoprost	Latanoprost	39	suppressed
Meloxicam	Meloxicam	39	14
Ondansetron Odt	Ondansetron	39	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	36	11
Levetiracetam	Levetiracetam	36	suppressed
Oxycodone Hcl	Oxycodone Hcl	34	15
Olmesartan Medoxomil	Olmesartan Medoxomil	33	suppressed
Celecoxib	Celecoxib	32	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	32	suppressed
Ozempic	Semaglutide	32	suppressed
Perphenazine	Perphenazine	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Aripiprazole	Aripiprazole	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	11
Nystatin	Nystatin	28	19
Ondansetron Hcl	Ondansetron Hcl	28	12
Valsartan	Valsartan	28	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	27	suppressed
Clonazepam	Clonazepam	27	suppressed
Glimepiride	Glimepiride	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	suppressed
Budesonide	Budesonide	23	suppressed
Cefuroxime	Cefuroxime Axetil	23	15
Mupirocin	Mupirocin	22	suppressed
Rivastigmine	Rivastigmine	22	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Azithromycin	Azithromycin	20	17
Fiasp Flextouch	Insulin Aspart (Niacinamide)	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Albuterol Sulfate	Albuterol Sulfate	18	suppressed
Alprazolam	Alprazolam	18	suppressed
Atenolol	Atenolol	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	13
Hydrocortisone	Hydrocortisone	17	suppressed
Baclofen	Baclofen	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	14
Alendronate Sodium	Alendronate Sodium	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Gemtesa	Vibegron	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Colchicine	Colchicine	13	suppressed
Desoximetasone	Desoximetasone	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Torsemide	Torsemide	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Megestrol Acetate	Megestrol Acetate	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Phenytoin	Phenytoin	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error